The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study - Trial SLCTR_2018_042
Access comprehensive clinical trial information for SLCTR_2018_042 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Durdans Hospital, 3, Alfred place, Colombo 3 and is currently Recruiting. The study focuses on Non-Alcoholic Fatty Liver Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2018_042
Early Phase 1
Recruiting
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2018_042
The effect of a synbiotic (probiotic and prebiotic) supplementation on patients with Non-Alcoholic Fatty Liver Disease (NAFLD): A proof of concept study
Study Focus
Interventional
Sponsor & Location
Durdans Hospital, 3, Alfred place, Colombo 3
Sri Lanka
Timeline & Enrollment
Early Phase 1
Jan 07, 2019
N/A
ICD-10 Classifications
Alcoholic fatty liver
Alcoholic liver disease, unspecified
Alcoholic liver disease
Liver disease, unspecified
Alcoholic cirrhosis of liver
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2018_042
Non-Device Trial